Vaccine News and Research

Latest Vaccine News and Research

Vaccine for Lassa fever set to enter clinical testing in humans

There is currently no vaccine for the Lassa arenavirus, which causes Lassa fever. This hemorrhagic fever, endemic in West Africa, infects up to 300,000 people each year.

24 Oct 2019

Scientists find new strains of human adenovirus in Singapore

Human adenovirus (HAdV) infections in Singapore and Malaysia have caused severe respiratory disease among children and adults in recent years, but scientists still don't know whether these outbreaks are due to new or re-emerging virus strains.

24 Oct 2019

Cooperative research center at LLNL aims to develop vaccines for chlamydia

A cooperative research center that aims to develop vaccines for chlamydia has been established by the National Institutes of Health at Lawrence Livermore National Laboratory.

24 Oct 2019

UAB researchers awarded grant to study a vaccine for gonorrhea

University of Alabama at Birmingham researchers have been awarded a three-year contract with a total potential amount of $10 million to study the efficacy of the vaccine Bexsero - already licensed to prevent meningitis - in protecting vulnerable populations from infection with the bacteria that causes gonorrhea.

23 Oct 2019

New study indicates a way to improve cancer immunotherapy

Cancer immunotherapy drugs trigger the body's immune system to attack tumors and have revolutionized the treatment of certain cancers, such as lymphoma, lung cancer and melanoma. Yet, while some patients respond well to the drugs, others don't respond at all. Cancer immunologists want to change that.

23 Oct 2019

New $30M contract signed to accelerate TB vaccine development across the country

Tuberculosis (TB) is the number-one cause of death from an infectious disease in the world: In 2017, the most recent data available, 10 million people developed TB and 1.6 million died.

23 Oct 2019

SEPATH: New template to detect oncogenic viruses and bacteria in human DNA

A new study from the University of East Anglia describes a novel approach to detecting bacteria and viruses that may possibly be causing cancer. Many such associations have already been found, such as HPV (human papilloma virus) infection in cervical cancer, and Helicobacter pylori (H. pylori) in stomach cancer.

22 Oct 2019

Ebola virus vaccine still effective against the infection even in low concentrations

The Ebola virus (EBOV), variant Makona, was the causative agent of the 2014-2016 West African epidemic that took over 11,000 lives and infected nearly 30,000 people. But with the combination of globally-supported containment efforts, health experts were able to track the spread of the outbreak, as well as use precautionary and quarantine procedures.

21 Oct 2019

School-based HPV immunization program dramatically reduces rates of cervical pre-cancer

A school-based human papillomavirus immunization program in British Columbia, Canada, is dramatically reducing rates of cervical pre-cancer in B.C. women, according to a new study.

21 Oct 2019

Highly diluted candidate Ebola vaccine remains fully protective against disease in macaques

A single dose of a highly diluted VSV-Ebola virus vaccine--approximately one-millionth of what is in the vaccine being used to help control the ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC)--remains fully protective against disease in experimentally infected monkeys, according to National Institutes of Health scientists.

18 Oct 2019

Novel approach brings researchers one step closer to universal flu vaccine

The scourge of the influenza virus devastates health and claims many lives worldwide each year. It is especially daunting because vaccines are only protective when they are well matched to the strains circulating in the population.

18 Oct 2019

Newly established Precision Immunotherapy Clinic matches cancer patients to latest treatments

A third occurrence of colon cancer and a failed immunotherapy clinical trial left Gordon Levine confined to a wheelchair with large tumors in his right hip bone, spine and lung, plus smaller tumors throughout his body, including one that caused an obstruction in his colon.

17 Oct 2019

Lyme vaccine on the horizon, says new study

Lyme disease is a dreaded disease caused by the bite of an infected tick. The only way to prevent it is by not getting bitten by the tick. However, this is not a practical recommendation, since even today about 300,000 thousand people are diagnosed with this infection, in the US alone, and over 100,000 in Europe, each year.

17 Oct 2019

Wistar receives major NIH grant to advance research on new melanoma targeted therapies

The Wistar Institute and collaborating institutions have received a major grant from the National Institutes of Health to further research on new melanoma targeted therapies integrating the role of the tumor microenvironment in influencing response to therapy and development of resistance.

17 Oct 2019

New paper defines strategy for developing effective vaccines for Lyme disease

There is no effective vaccine currently available to prevent Lyme disease in humans.

17 Oct 2019

Study: Mathematical modeling is key to predicting and controlling disease outbreaks

Predicting and controlling disease outbreaks would be easier and more reliable with the wider application of mathematical modeling, according to a new study.

17 Oct 2019

Computer model predicts location of future Ebola virus outbreaks

The Ebola virus disease (EVD) is a deadly infection that is highly contagious. It has taken thousands of lives across history, with a number of outbreaks mostly happening in West Africa. In the worse outbreak, between 2014 and 2016, there had been 28,616 cases of EVD, 11,310 of whom had died in the continent. Overseas, there had been 36 cases and 15 deaths.

16 Oct 2019

UTEP awarded $19.2 million NIH grant to study cancer affecting Mexican-American population

The University of Texas at El Paso's Border Biomedical Research Center will accelerate its quest to understand and identify the reasons for Hispanic cancer health disparities and its ultimate impact on the people of the Paso del Norte region thanks to a five-year, $19.2 million grant from the National Institutes of Health.

16 Oct 2019

Scientists discover how malaria switched host from African gorillas to humans

Researchers have revealed the series of events that probably led to the world’s deadliest form of malaria being able to jump from ancient great apes to humans.

16 Oct 2019

NIH awards new contract to integrate pathogen and vector genomics database

A team led by scientists at the University of Pennsylvania and University of Georgia provides thousands of researchers around the world with access to the Eukaryotic Pathogen Genomics Database (EuPathDB.org), a collection of resources for analyzing large-scale datasets associated with microbial pathogens.

16 Oct 2019